Schedule 13D ownership disclosure
THERAPIX BIOSCIENCES LTD
Security class unavailable · CUSIP: 88339A203
Event date: 2020-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.5900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-016413
- Form type
- SC 13D
- Filer
- L.I.A. Pure Capital Ltd
- CIK
- CIK 1749628
- Filed
- Jul 01, 2020
- Reporting period
- Jun 30, 2020
- Description
- Schedule 13D beneficial ownership